Drug Trial Radar · NCT06558344
A Study to Test Different Doses of BI 1569912 in People With Depression
Last checked: Nov 20, 2026Latest source record: May 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
225
Actual
Start
Oct 1, 2024
Primary completion
May 2, 2025
Study completion May 12, 2025
Sponsor
- Lead sponsor
- Boehringer IngelheimBoehringer Ingelheim
- Sponsor type
- Industry
- First posted
- Aug 16, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is open to adults between 18 and 65 years of age with a type of depression called major depressive disorder. The purpose of the study is to find out whether a medicine called BI 1569912 helps people with depression. Participants are put into 4 groups randomly, which means by chance. Three of the 4 groups take different doses of BI 1569912 and 1 group takes placebo. Placebo tablets looks like BI 1569912 but do not contain any medicine. Participants take the tablets once a day for 6 weeks. Participants are in the study for about 2.5 months. During this time, they visit the study site at least 7 times. At the visits, doctors and their staff ask participants about their depression symptoms. At the end of the study, the results are compared between the groups to see whether the treatment works. The doctors also regularly check the general health of participants and take note of any unwanted effects.
Conditions
- Depressive Disorder, Major
Interventions
5 mg BI 1569912Drug
Two 2.5 mg tablets of BI 1569912
Placebo matching BI 1569912Drug
Placebo matching BI 1569912
10 mg BI 1569912Drug
One 10 mg tablet of BI 1569912
20 mg of BI 1569912Drug
Two 10 mg tablets of BI 1569912
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in MADRS Total Score at Week 6Time frame: MMRM included measurements at baseline, Day 8, Week 2, Week 4, and Week 6. Change from baseline values at Week 6 is reported.
Locations
41 sites in 2 countries. Site status is shown where the registry gives one.
Clinical Innovations, Inc
Bellflower, California
ASCLEPES Research Centers, P.C. dba Alliance Research
Long Beach, California
Excell Research Inc.
Oceanside, California
CiTrials-Riverside-63180
Riverside, California
Artemis Institute for Clinical Research, LLC
San Diego, California
Lumos Clinical Research
San Jose, California
California Neuroscience Research
Sherman Oaks, California
Pacific Clinical Research Management Group LLC
Upland, California
Research Centers of America-Hollywood-67537
Hollywood, Florida
Clinical Neuroscience Solutions, Inc-Jacksonville-62642
Jacksonville, Florida
CCM Clinical Research Group, LLC-Miami-68482
Miami, Florida
Optimus U Corporation-Miami-69452
Miami, Florida
Clinical Neuroscience Solutions, Inc-Orlando-62685
Orlando, Florida
Advanced Discovery Research LLC
Atlanta, Georgia
iResearch Atlanta
Decatur, Georgia
Psych Atlanta, PC
Marietta, Georgia
Pharmasite Research, Incorporated
Baltimore, Maryland
Copley Clinical
Boston, Massachusetts
Boston Clinical Trials
Roslindale, Massachusetts
Adams Clinical
Watertown, Massachusetts
Psychiatric Care and Research Center
O'Fallon, Missouri
ActivMed
Portsmouth, New Hampshire
Center For Emotional Fitness
Cherry Hill, New Jersey
Bio Behavioral Health
Toms River, New Jersey
Integrative Clinical Trials LLC
Brooklyn, New York
Neurobehavioral Research, Inc.
Cedarhurst, New York
Berman Clinical
New York, New York
Davis Clinical
The Bronx, New York
Sooner Clinical Research, Inc
Oklahoma City, Oklahoma
Surburban Research Associates, Inc.
Media, Pennsylvania
Clinical Neuroscience Solutions, Inc-Memphis-65988
Memphis, Tennessee
FutureSearch Trials of Dallas, LP
Dallas, Texas
Grayline Research Center
Wichita Falls, Texas
Northwest Clinical Research Center
Bellevue, Washington
Core Clinical Research
Everett, Washington
Uematsu Mental Clinic
Fukuoka, Chikugo, Japan
Kaku Mental Clinic
Fukuoka, Fukuoka, Japan
Hirota Clinic
Fukuoka, Kurume, Japan
Yutaka Clinic
Kanagawa,Sagamihara, Japan
Maynds Tower Mental Clinic
Tokyo, Shibuya-ku, Japan
Showing 40 of 41 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.